Cytoreductive Surgery (CRS)

CRS is a complex intervention that may involve the removal of several abdominal organs, including portions of the colon, the gallbladder, the spleen, or parts of the stomach, to ensure all tumor deposits are cleared. Because this is a high-stakes procedure, it is performed in specialized centers by surgeons with advanced training in peritoneal oncology. The meticulous nature of this surgery is what allows it to offer patients a chance at long-term disease control in scenarios where other treatment options may be limited.

Not every patient with abdominal cancer spread is a candidate for CRS. Eligibility is determined through a rigorous assessment process, including detailed cross-sectional imaging (like CT or PET/CT scans) and, often, a diagnostic laparoscopy to map the extent of the disease. Factors such as the patient's overall fitness, the biological behavior of the cancer, and the potential for achieving a complete resection are critical. We prioritize a patient-centered approach to ensure that the expected benefits outweigh the risks of this major surgical undertaking.

Recovery from CRS is a journey that requires time, patience, and dedicated rehabilitation. Patients typically spend time in the Intensive Care Unit (ICU) immediately following surgery, followed by a hospital stay focused on nutritional stabilization and physical recovery. Our clinical team works closely with each patient to manage pain, ensure adequate nutrition, and guide them through the post-operative healing phase. We are committed to providing continuous, supportive care throughout the entire recovery process.